{
  "id": "clinical#screening_cues_e392a991",
  "content": "other hallucinogen depressive episode with\nintoxication, 249–250 short-duration\nother hallucinogen use hypomania, 82\ndisorder, 246–248 other specified bipolar and\nother phencyclidine-induced related disorder, 82\ndisorders, 251\nphencyclidine intoxication,\nICD. See International\n248–249\nClassification of Diseases\nphencyclidine use disorder,\nICF (International Classification\n244–246\nunspecified hallucinogen- of Functioning, Disability\nrelated disorder, 252 and Health), 6\nunspecified phencyclidine- Illness anxiety disorder, 162\nrelated disorder, 252 brief, 166\nHistrionic personality disorder, without excessive health-\n326 related behaviors, 166\nHIV infection, major or mild Inhalant-related disorders, 227,\nneurocognitive disorder 252–256\ndue to, 303, 315–316 inhalant intoxication, 254–255\nHoarding disorder, 132–133 inhalant use disorder,\n252–254\nHousing problems, 368–369\nother inhalant-induced\nHuntington’s disease, major or\ndisorders, 255\nmild neurocognitive\nunspecified inhalant-related\ndisorder due to, 303, disorder, 256\n317–318 Insomnia disorder, 181–182\nHypersomnolence disorder, brief, 198\n182–183 other specified, 197–198\nother specified, 198–199 restricted to nonrestorative\nunspecified, 199 sleep, 198\nHypomanic episode or unspecified, 198\nsymptoms in bipolar and Intellectual disability (intellectual\nrelated disorders developmental disorder), 23\nbipolar I disorder, 66–67 global developmental delay,\nbipolar II disorder, 71–72 23\nbipolar and related disorder severity levels for, 19–22\ndue to another medical unspecified, 23\ncondition, 81 Intermittent explosive disorder,\ncyclothymic disorder, 76 220–221\n384 Index",
  "metadata": {
    "source": "DSM-5",
    "url": "https://psychiatry.org/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "sleep",
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues other hallucinogen depressive episode with\nintoxication, 249–250 short-duration\nother hallucinogen use hypomania, 82\ndisorder, 246–248 other specified bipolar and\nother phencyclidine-induced related disorder, 82\ndisorders, 251\nphencyclidine intoxication,\nICD. See International\n248–249\nClassification of Diseases\nphencyclidine use disorder,\nICF (International Classification\n244–246\nunspecified hallucinogen- of Functioning, Disability\nrelated disorder, 252 and Health), 6\nunspecified phencyclidine- Illness anxiety disorder, 162\nrelated disorder, 252 brief, 166\nHistrionic personality disorder, without excessive health-\n326 related behaviors, 166\nHIV infection, major or mild Inhalant-related disorders, 227,\nneurocognitive disorder 252–256\ndue to, 303, 315–316 inhalant intoxication, 254–255\nHoarding disorder, 132–133 inhalant use disorder,\n252–254\nHousing problems, 368–369\nother inhalant-induced\nHuntington’s disease, major or\ndisorders, 255\nmild neurocognitive\nunspecified inhalant-related\ndisorder due to, 303, disorder, 256\n317–318 Insomnia disorder, 181–182\nHypersomnolence disorder, brief, 198\n182–183 other specified, 197–198\nother specified, 198–199 restricted to nonrestorative\nunspecified, 199 sleep, 198\nHypomanic episode or unspecified, 198\nsymptoms in bipolar and Intellectual disability (intellectual\nrelated disorders developmental disorder), 23\nbipolar I disorder, 66–67 global developmental delay,\nbipolar II disorder, 71–72 23\nbipolar and related disorder severity levels for, 19–22\ndue to another medical unspecified, 23\ncondition, 81 Intermittent explosive disorder,\ncyclothymic disorder, 76 220–221\n384 Index Other hallucinogen depressive episode with\nintoxication, 249–250 short-duration\nother hallucinogen use hypomania, 82\ndisorder, 246–248 other specified bipolar and\nother phencyclidine-induced related disorder, 82\ndisorder..."
}